Summary: Psychedelic researchers Charlotte Harrison and Dr. Michael Mithoefer of MAPS Public Benefit Corporation speak to Radio Health Journal in a new podcast interview that explores how MDMA-assisted psychotherapy for PTSD differs from current treatment options.
Audio recording originally appearing here.
People suffering from post-traumatic stress disorder often can’t face their trauma, which is necessary for psychotherapy to work. It is a big reason PTSD is so difficult to treat. Scientists are leading clinical trials into the use of the banned drug MDMA in connection with therapy to help break this hurdle, and the results so far have been outstanding in curing PTSD.